## **Core Concept**
The question tests the understanding of the HIV entry mechanism, specifically the interaction between the HIV envelope glycoproteins and the host cell receptor. HIV entry into host cells is a critical step in the viral life cycle.

## **Why the Correct Answer is Right**
The envelope glycoprotein gp120 of HIV specifically binds to the **CD4 receptor** on the surface of host immune cells, such as T helper cells. This binding is crucial for the viral entry process. After gp120 binds to CD4, it undergoes a conformational change that allows it to bind to a co-receptor, typically CCR5 or CXCR4, facilitating the fusion of the viral envelope with the host cell membrane. The CD4 receptor is a primary receptor for HIV attachment, making it a target for therapeutic interventions.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Incorrect because while HIV does interact with co-receptors like CCR5 or CXCR4, gp120's initial and specific binding is to the CD4 receptor, not directly to these co-receptors.
- **Option B:** Incorrect as there is no commonly recognized HIV receptor or co-receptor designated by this option in the context of HIV entry.
- **Option C:** This option is not provided, but based on the correct answer, we know the focus is on CD4.
- **Option D:** Incorrect for similar reasons as Option A; while integrin and other molecules might interact with HIV or influence entry indirectly, gp120 specifically binds to CD4.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that the interaction between gp120 and CD4 is a critical target for antiretroviral therapy (ART). Drugs like **Maraviroc** target the co-receptor (CCR5) that HIV uses to enter cells after gp120-CD4 binding, illustrating the importance of understanding HIV entry mechanisms for developing treatments.

## **Correct Answer:** . CD4 receptors